Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

T-Epivaccines

PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a cancer therapy. The company develops immunotherapy for lungs and prostate cancer.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore T-Epivaccines’s full profile, request a free trial.

T-Epivaccines Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

T-Epivaccines Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
The Institut Pasteur Accelerator/Incubator 000 0000 000000 0

T-Epivaccines Executive Team (1)

Name Title Board
Seat
Contact
Info
Konstadinos Kosmatopoulos MD Founder